|
End-of-day quote
Shenzhen S.E.
2026-07-21
|
5-day change
|
1st Jan Change
|
|
41.59 CNY
|
+1.12%
|
 |
+1.96%
|
-14.20%
|
|
06-30 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
|
CI
| |
06-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
|
CI
| |
05-24 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. cancelled the transaction announced on May 27, 2025
|
CI
| |
05-15 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2025, Payable on 22 May 2026
|
CI
| |
04-27 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
04-21 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
01-05 |
Xingqi Pharmaceutical Gets Nod for Supplementary Application for Atropine Sulfate Eye Drops
|
MT
| |
12-08 |
Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue
|
MT
| |
25-10-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
25-09-16 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Interim Cash Dividend on A Shares for 2025, Payable on 24 September 2025
|
CI
| |
25-08-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Cash Dividend for the Year 2025
|
CI
| |
25-08-27 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
25-05-15 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Final Cash Dividend Plan on A Shares for 2024, Payable on 22 May 2025
|
CI
| |
25-04-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
25-04-22 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2024
|
CI
| |
25-04-20 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
|
CI
| |
24-10-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
|
CI
| |
24-09-18 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Interim Cash Dividend for the 2024
|
CI
| |
24-08-29 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Profit Distribution for First Half of 2024
|
CI
| |
24-08-28 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
|
CI
| |
24-07-25 |
Xingqi Pharmaceutical Gets Nod to Trial Eye Drops; Shares Up 4%
|
MT
| |
24-07-24 |
Xingqi Pharmaceutical Gets Nod to Register Bromfenac Sodium Eye Drops; Shares Down 3%
|
MT
| |
24-05-15 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024
|
CI
| |
24-04-25 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| |
24-04-18 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
|
CI
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
